Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Tacrolimus | Prograf | 4.8. Undesirable effects | Nephrotoxicity, febrile neutropenia, posterior reversible encephalopathy syndrome | Jun, 2024 |
| Azacitidine | Vidaza | 4.8. Undesirable effects | Cutaneous vasculitis | Jun, 2024 |
| Rituximab | Ruxience | 4.4 Special Warnings and Special Precautions for Use | Enteroviral meningoencephalitis | Jun, 2024 |
| Carvedilol | dilatrend | 4.4 Special Warnings and Special Precautions for Use | Risk of Anaphylactic Reaction | Jun, 2024 |
| Loperamide hydrochloride | Imodium orodispersible tablet | 4.8. Undesirable effects | Acute pancreatitis | Jun, 2024 |
| Tofacitinib Citrate | Xeljanz | 4.8. Undesirable effects | Acne | Jun, 2024 |